<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30305" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Amphetamine Toxicity</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vasan</surname>
            <given-names>Sarayu</given-names>
          </name>
          <aff>UCLA - Kern Medical</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Murray</surname>
            <given-names>Brian P.</given-names>
          </name>
          <aff>Wright State University Boonshoft School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Olango </surname>
            <given-names>Garth J.</given-names>
          </name>
          <aff>UCLA-Kern/Kern Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sarayu Vasan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Brian Murray declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Garth Olango declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>6</day>
          <month>5</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30305.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Amphetamine abuse remains prevalent in the United States (US), with significant implications for public health and individual well-being. The ramifications of amphetamine toxicity and overdose are profound, contributing to substantial morbidity and mortality rates. Notably, amphetamines' sympathomimetic properties precipitate adverse cardiovascular and neurological effects, with studies indicating their involvement in a significant proportion of drug-related deaths in the US. Symptoms of amphetamine toxicity span a spectrum, encompassing tachycardia, hypertension, impulsivity, aggression, serotonin syndrome, psychosis, and seizures, underscoring the complexity of its clinical manifestations.&#x000a0;</p>
        <p>In this course, participants explore the multifaceted management of amphetamine toxicity. The dynamics of both acute and chronic amphetamine use and their profound impacts on cardiovascular, neurological, and psychiatric systems&#x000a0;are discussed. Recognizing symptoms of amphetamine toxicity, such as tachycardia, hypertension, and serotonin syndrome, while recognizing the limitations of relying solely on drug metabolite testing for diagnosis, is also explored. Furthermore, collaboration and communication among interprofessional teams are &#x000a0;emphasized, as this enhances patient outcomes by leveraging the expertise of diverse healthcare professionals.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Differentiate between acute and chronic effects of amphetamine use to tailor appropriate management strategies. &#x000a0;</p></list-item><list-item><p>Interpret laboratory and radiologic findings to confirm amphetamine toxicity and rule out alternative diagnoses.</p></list-item><list-item><p>Screen patients for amphetamine use disorders and assess their risk of toxicity based on history and clinical presentation.</p></list-item><list-item><p>Communicate effectively with interdisciplinary teams to coordinate comprehensive care for patients with amphetamine toxicity.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30305&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30305">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30305.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Amphetamine abuse is widespread and associated with a significant impact on cardiovascular and neurological systems in overdose. In many parts of the world, amphetamines have been an abused class of drugs since the 1930s. Methamphetamine (METH) and its derivative, 3,4-methylenedioxymethamphetamine (MDMA), are extensively abused drugs, and the acute effects of these drugs include increased alertness, hyperthermia, decreased appetite, and euphoria. However, long-term abuse can result in neurotoxicity and psychosis. Amphetamines increase the neurotransmission of dopamine (DA), serotonin (5-HT), and norepinephrine (NE) by entering neurons via the 5-HT and DA transporters and displacing storage vesicles. MDMA has a greater affinity for 5-HT transporters, causing an increased release of 5-HT. The clinical effects of amphetamine overdose are significant and usually observed in emergency departments.<xref ref-type="bibr" rid="article-30305.r1">[1]</xref><xref ref-type="bibr" rid="article-30305.r2">[2]</xref><xref ref-type="bibr" rid="article-30305.r3">[3]</xref></p>
      </sec>
      <sec id="article-30305.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Amphetamine use, both acute and chronic, may lead to amphetamine toxicity. Amphetamine use has increased steadily over time.<xref ref-type="bibr" rid="article-30305.r4">[4]</xref>&#x000a0;The reasons for the increased use of amphetamines are numerous, including a sustained desire for favorable drug effects like euphoria, mood elevation, and appetite suppression, the availability of amphetamine compounds as both legal and illegal substances, an increase in the production of amphetamines for sale in the illegal drug trade, and the affordability of illicit amphetamines as compared to other illicit drugs.<xref ref-type="bibr" rid="article-30305.r4">[4]</xref>&#x000a0;Recently, stress and anxiety related to the COVID-19 pandemic may have also contributed to increased amphetamine use.<xref ref-type="bibr" rid="article-30305.r5">[5]</xref>&#x000a0;Amphetamine dependence is not a prerequisite for toxicity, but those who become dependent on amphetamines may be at higher risk of experiencing it. Dependence is likely due to increased tolerance to amphetamine effects and the requirement of escalating doses to achieve the desired effect.&#x000a0;</p>
      </sec>
      <sec id="article-30305.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>In 2021, it was estimated that 36 million people used amphetamines across the globe. The majority of amphetamine users (55%)&#x000a0;are men.&#x000a0;For&#x000a0;people undergoing treatment for drug use disorders, amphetamines are the primary drug of abuse 18% of the time in the Americas and 42% of the time in Asia.[<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.unodc/unodc/data-and-analysis/world-drug-report-2023.html">United Nations Office of Drugs and Crime World Drug Report, 2023</ext-link>]&#x000a0;The 2023 "Monitoring the Future Survey" estimated that 2.1% of adolescents in the US used&#x000a0;illicit amphetamines.[<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://monitoringthefuture.org/wp-content/uploads/2023/12/mtf2023.pdf">Monitoring the Future National Survey Results on Drug Use, 1975-2023</ext-link>]&#x000a0;Additionally, an estimated 1.8 million Americans 12 years and older have a methamphetamine use disorder.[<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://samhsa.gov/data/sites/default/files/reports/rpt42731/2022-nsduh-nnr.pdf">SAMHSA NSDUH, 2022</ext-link>]</p>
      </sec>
      <sec id="article-30305.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Amphetamines are structural analogs of the neurotransmitter phenethylamine (see <bold>Image.</bold>&#x000a0;Phenethylamine Chemical Structure and <bold>Image.</bold> Amphetamine Chemical Structure), which regulates monoamine neurotransmission through the modulation of the trace amine-associated receptor 1 (TAAR1) and inhibition of the vesicular monoamine transporter 2 (VMAT2). TAAR1 is expressed in multiple locations within the central nervous system (CNS), including the dorsal and ventral caudate nucleus, putamen, substantia nigra, nucleus accumbens, ventral tegmental area, locus ceruleus, amygdala, and raphe nucleus.<xref ref-type="bibr" rid="article-30305.r6">[6]</xref>&#x000a0;Many of these areas play&#x000a0;important roles in the development of addiction. Thus, the use of amphetamines begets the desire to continue using amphetamines.</p>
        <p>The effects of TAAR1 agonism may extend beyond the central nervous system. Downstream effects from receptor activation may lead to increased reactive oxygen species, mitochondrial dysfunction, and alterations in intracellular calcium. These metabolic abnormalities have been implicated in the accelerated development of cardiovascular disease.<xref ref-type="bibr" rid="article-30305.r7">[7]</xref><xref ref-type="bibr" rid="article-30305.r8">[8]</xref><xref ref-type="bibr" rid="article-30305.r9">[9]</xref>&#x000a0;Amphetamines also cause necrotizing vasculitis of small- and medium-sized blood vessels, which can yield a myriad of end-organ complications (strokes and neurodegenerative diseases, coronary artery disease, ischemic bowel disease). The underlying etiology is not well understood and may result from the amphetamines or potential adulterants or contaminants.<xref ref-type="bibr" rid="article-30305.r10">[10]</xref><xref ref-type="bibr" rid="article-30305.r11">[11]</xref><xref ref-type="bibr" rid="article-30305.r12">[12]</xref><xref ref-type="bibr" rid="article-30305.r13">[13]</xref><xref ref-type="bibr" rid="article-30305.r14">[14]</xref>&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-30305.s6" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>Amphetamine has&#x000a0;an oral bioavailability of about 75%. Peak plasma concentrations&#x000a0;are found approximately 3 hours after ingestion. Peak cardiovascular effects occur approximately 1 hour after ingestion, while behavioral changes&#x000a0;are seen around&#x000a0;2 hours after ingestion.<xref ref-type="bibr" rid="article-30305.r15">[15]</xref>&#x000a0;No ceiling effect has been noted.<xref ref-type="bibr" rid="article-30305.r16">[16]</xref>&#x000a0;However, these effects are relatively short-lived, owing to a rapid decline in monoamine release after peak concentrations are reached. Amphetamine is hepatically metabolized by multiple enzymes, including (cytochrome) CYP2D6, dopamine&#x000a0;&#x003b2;-hydroxylase, and flavin-containing monooxygenase-3.<xref ref-type="bibr" rid="article-30305.r17">[17]</xref>&#x000a0;Only 30% to 40% of amphetamine is&#x000a0;eliminated as an unchanged drug in the urine. An acidic urine pH traps amphetamine in the renal tubules and decreases its elimination half-life.<xref ref-type="bibr" rid="article-30305.r18">[18]</xref>&#x000a0;</p>
        <p>Methamphetamine can be ingested orally, insufflated nasally, smoked, or injected intravenously.&#x000a0;Bioavailability is reliable (~70% or greater) with these ingestion routes.&#x000a0;Peak serum concentrations of methamphetamine occur approximately 3 to 6 hours after oral ingestion. Nasal insufflation leads to a peak serum concentration in 5 to 10 minutes, and smoking leads to peak serum concentrations within 5 minutes. Methamphetamine is more lipophilic than amphetamine and is less prone to metabolism by monoamine oxidase. Methamphetamine is hepatically metabolized and renally eliminated, similarly to amphetamine.&#x000a0;</p>
      </sec>
      <sec id="article-30305.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Amphetamines are used&#x000a0;for fatigue, appetite suppression, and narcolepsy treatment. Patients experiencing amphetamine toxicity thus often present with&#x000a0;anorexia, dehydration, weight loss, and insomnia. Patients may be highly agitated, even to the&#x000a0;point of risking the safety of healthcare staff and themselves. Patients should be asked what drug(s) they used, the route of administration they utilized, and the duration of their drug use.&#x000a0;Blood pressure, heart rate, and other vital&#x000a0;signs should be taken immediately upon presentation. The physical examination should include assessments for&#x000a0;hyperthermia, evidence of end-organ damage (eg, neurological deficits, respiratory compromise, or new cardiac murmurs), and skin ulcerations or abscesses.&#x000a0;</p>
      </sec>
      <sec id="article-30305.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>When patients appear intoxicated and have symptoms consistent with amphetamine toxicity, testing for&#x000a0;metabolites of amphetamine can be useful to confirm a diagnosis of the condition. However, ingestion of some amphetamines, including&#x000a0;3,4-methylenedioxymethamphetamine, will not reliably&#x000a0;result in a positive&#x000a0;test for the presence of&#x000a0;amphetamines.<xref ref-type="bibr" rid="article-30305.r19">[19]</xref><xref ref-type="bibr" rid="article-30305.r20">[20]</xref>&#x000a0;Conversely, some non-amphetamine medications may cause false-positive results for the presence of amphetamines. These drugs include pseudoephedrine,<xref ref-type="bibr" rid="article-30305.r21">[21]</xref> mebeverine,<xref ref-type="bibr" rid="article-30305.r22">[22]</xref> metoprolol,<xref ref-type="bibr" rid="article-30305.r23">[23]</xref> tetracaine,<xref ref-type="bibr" rid="article-30305.r24">[24]</xref> dimethylamylamine,<xref ref-type="bibr" rid="article-30305.r25">[25]</xref> aripiprazole,<xref ref-type="bibr" rid="article-30305.r26">[26]</xref> and ranitidine.<xref ref-type="bibr" rid="article-30305.r27">[27]</xref>&#x000a0;Thus, clinicians should not rely on drug metabolite testing alone to make a diagnosis of amphetamine toxicity. Obtaining an accurate medication history for the patient may allow a diagnosis to be made&#x000a0;independently of drug metabolite testing. Therefore, obtaining medication histories should always be a focus during the evaluation of patients who are intoxicated.</p>
        <p>Additionally, laboratory and radiologic evaluation for patients with suspected amphetamine toxicity should focus on confirming that the toxic effects of amphetamines are present and ruling out other causes for them. Dehydration and hyponatremia may be confirmed with a basic metabolic panel. An electrocardiogram, chest x-ray, and troponin test are necessary to assess the presence of coronary ischemia, including myocardial infarction and aortic dissection. Computed tomography of the head is also useful to assess hemorrhagic stroke as a potential cause of neurologic deficits. Finally, obtaining serum creatine kinase and lactic acid levels may help identify muscle damage and tissue ischemia related to tonic-clonic seizures, myoclonus, or hyperthermia.&#x000a0;</p>
      </sec>
      <sec id="article-30305.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treating amphetamine toxicity is supportive.&#x000a0;There are no specific antidotes for amphetamine or amphetamine-like compounds. Therefore, treatment should focus on symptom and complication management. Patients with agitation should&#x000a0;be treated&#x000a0;with parenteral benzodiazepines. Diazepam is an ideal choice if intravenous access is available; otherwise, intramuscular lorazepam or midazolam is appropriate.&#x000a0;</p>
        <p>Patients who present with delirium may benefit from adjunctive treatment with a dopamine antagonist, like haloperidol. However, while the dopamine blockade can help treat the psychiatric and psychomotor disorders associated with amphetamine toxicity, these agents may cause harm. They can decrease the seizure threshold,<xref ref-type="bibr" rid="article-30305.r28">[28]</xref>&#x000a0;cause extrapyramidal side effects, increase heat production by altering thermoregulatory function,<xref ref-type="bibr" rid="article-30305.r29">[29]</xref><xref ref-type="bibr" rid="article-30305.r30">[30]</xref><xref ref-type="bibr" rid="article-30305.r31">[31]</xref>&#x000a0;and prolong the QTc interval.&#x000a0;Thus, judicious and cautious use of these agents in the setting of amphetamine toxicity is required.&#x000a0;</p>
        <p>Hypertension related to amphetamine toxicity may abate with agitation treatment. However, some patients may require antihypertensive treatment to combat hypertensive urgency or emergency. Peripheral vasodilators like nitroglycerin and nicardipine may be effective in lowering blood pressure. Beta-blockers should&#x000a0;not be used as sole antihypertensive therapies as their use may lead to unopposed &#x003b1;-adrenergic tone and a worsened hypertensive state. Similarly to hypertension, hyperthermia may abate with the treatment of agitation. However, external cooling with ice baths, misting, or cooled IV fluids may also be required to achieve euthermia. External cooling therapies should&#x000a0;be rapidly administered&#x000a0;when patients present with temperatures exceeding 107&#x000a0;&#x000b0;F.&#x000a0;&#x000a0;</p>
        <p>Seizures should initially&#x000a0;be treated&#x000a0;with parenteral benzodiazepines. Barbiturates and propofol may&#x000a0;be added&#x000a0;for further seizure control. Phenytoin, fosphenytoin, and valproic acid should&#x000a0;be avoided&#x000a0;due to their ineffectiveness in aborting toxicologic seizures.&#x000a0;There are no approved treatments for amphetamine use disorder. Naltrexone has&#x000a0;been evaluated&#x000a0;for this indication based on its ability to decrease the effects of the dopamine reward system. Some studies have shown promising results for naltrexone.<xref ref-type="bibr" rid="article-30305.r32">[32]</xref><xref ref-type="bibr" rid="article-30305.r33">[33]</xref>&#x000a0;In contrast, others have shown&#x000a0;a lack of appreciable effects on cravings or amphetamine use.<xref ref-type="bibr" rid="article-30305.r34">[34]</xref><xref ref-type="bibr" rid="article-30305.r35">[35]</xref><xref ref-type="bibr" rid="article-30305.r36">[36]</xref>&#x000a0;However, many of these studies were conducted on animals. There is an overall paucity of high-quality data from human subjects to base conclusions on naltrexone's efficacy. As a result, consultation with an addiction specialist, cognitive behavioral therapy, and group therapy remain the primary means to treat amphetamine use disorder.</p>
      </sec>
      <sec id="article-30305.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>To diagnose amphetamine toxicity, other&#x000a0;toxicities need to be explored, including&#x000a0;toxicities to cocaine, methylxanthine, phencyclidine, and other sympathomimetics. Neurocognitive disorders and stroke should also be ruled out. Schizophrenia, mania, alcohol withdrawal, and meningitis should also be considered.</p>
      </sec>
      <sec id="article-30305.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Clinicians should screen patients experiencing amphetamine toxicity for complications related to the sympathetic surge that accompanies it. These complications include&#x000a0;hemorrhagic strokes,<xref ref-type="bibr" rid="article-30305.r37">[37]</xref><xref ref-type="bibr" rid="article-30305.r38">[38]</xref><xref ref-type="bibr" rid="article-30305.r39">[39]</xref>&#x000a0;seizures,<xref ref-type="bibr" rid="article-30305.r40">[40]</xref> hyperthermia,<xref ref-type="bibr" rid="article-30305.r41">[41]</xref><xref ref-type="bibr" rid="article-30305.r42">[42]</xref> serotonin syndrome, acute coronary syndrome,<xref ref-type="bibr" rid="article-30305.r43">[43]</xref><xref ref-type="bibr" rid="article-30305.r44">[44]</xref>, cardiomyopathy,<xref ref-type="bibr" rid="article-30305.r45">[45]</xref><xref ref-type="bibr" rid="article-30305.r46">[46]</xref> cardiac valvulopathies,<xref ref-type="bibr" rid="article-30305.r47">[47]</xref><xref ref-type="bibr" rid="article-30305.r48">[48]</xref> aortic dissection,<xref ref-type="bibr" rid="article-30305.r49">[49]</xref><xref ref-type="bibr" rid="article-30305.r50">[50]</xref>&#x000a0;rhabdomyolysis,<xref ref-type="bibr" rid="article-30305.r51">[51]</xref> dehydration, acute kidney injury, arrhythmias, and hyponatremia.<xref ref-type="bibr" rid="article-30305.r52">[52]</xref>&#x000a0;Additionally, amphetamine toxicity may result in widespread vasospasm. These widespread vasospastic effects can cause ischemia anywhere in the body, including the bowel.<xref ref-type="bibr" rid="article-30305.r53">[53]</xref><xref ref-type="bibr" rid="article-30305.r54">[54]</xref><xref ref-type="bibr" rid="article-30305.r55">[55]</xref><xref ref-type="bibr" rid="article-30305.r56">[56]</xref>&#x000a0;Lastly, amphetamine intoxication&#x000a0;may be associated with psychosis, paranoid delusions, and hallucinations that resemble schizophrenia.<xref ref-type="bibr" rid="article-30305.r57">[57]</xref><xref ref-type="bibr" rid="article-30305.r58">[58]</xref><xref ref-type="bibr" rid="article-30305.r59">[59]</xref>&#x000a0;&#x000a0;</p>
        <p>Patients who chronically use amphetamines have an increased risk of developing pulmonary hypertension,<xref ref-type="bibr" rid="article-30305.r60">[60]</xref><xref ref-type="bibr" rid="article-30305.r61">[61]</xref><xref ref-type="bibr" rid="article-30305.r62">[62]</xref>&#x000a0;heart failure, and embolic strokes. Additionally, patients who chronically use amphetamines often have poor nutritional status,&#x000a0;<xref ref-type="bibr" rid="article-30305.r63">[63]</xref><xref ref-type="bibr" rid="article-30305.r64">[64]</xref>&#x000a0;oral hygiene, and widespread skin lesions.<xref ref-type="bibr" rid="article-30305.r65">[65]</xref><xref ref-type="bibr" rid="article-30305.r66">[66]</xref>&#x000a0;Frequently,&#x000a0;skin lesions result from delusions parasitosis, or Ekbom syndrome, where patients pick&#x000a0;at their skin to remove imaginary insects.<xref ref-type="bibr" rid="article-30305.r67">[67]</xref>&#x000a0;Chronic use of amphetamines can also cause choreoathetoid movements, which can persist&#x000a0;from weeks to years after cessation of amphetamine use.<xref ref-type="bibr" rid="article-30305.r68">[68]</xref><xref ref-type="bibr" rid="article-30305.r69">[69]</xref></p>
      </sec>
      <sec id="article-30305.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>When treating a patient with an amphetamine use disorder, it is important to first medically stabilize them and then discuss the complications associated with use and ascertain their readiness for help and treatment. If they desire treatment and sobriety, they should be connected to an outpatient clinic that can provide further management.&#x000a0;</p>
      </sec>
      <sec id="article-30305.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Physicians, advanced practitioners, nurses, pharmacists, and other healthcare professionals play critical roles in managing amphetamine toxicity. They must accurately identify symptoms, assess severity, and differentiate toxicity from other conditions, utilizing comprehensive evaluations and medication histories. Effective communication and collaboration among team members facilitate coordinated care, ensuring patient safety and optimized outcomes.&#x000a0;Clinicians must also apply evidence-based strategies in symptom management and complication prevention, utilizing supportive care approaches. Continuous evaluation and improvement of interventions enhance patient-centered care, promoting a holistic approach to addressing amphetamine abuse and associated toxicities.</p>
      </sec>
      <sec id="article-30305.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30305&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30305">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/addiction/amphetamine-toxicity-amphetamine-overdose/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=30305">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30305/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30305">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-30305.s15">
        <fig id="article-30305.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Amphetamine Chemical Structure. The illustration describes the structure of the stimulant amphetamine. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://commons.wikimedia.org/w/index.php?search=Amphetamine+Chemical+Structure&#x00026;title=Special:MediaSearch&#x00026;go=Go&#x00026;type=image">Public Domain</ext-link>&#x000a0;via Wikimedia Commons</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Phenethylamine" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-30305.s16">
        <fig id="article-30305.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Structure of amphetamine. creative commons license</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="amphetamine" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-30305.s17">
        <title>References</title>
        <ref id="article-30305.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Limanaqi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gambardella</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Biagioni</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Busceti</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Fornai</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Epigenetic Effects Induced by Methamphetamine and Methamphetamine-Dependent Oxidative Stress.</article-title>
            <source>Oxid Med Cell Longev</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>4982453</fpage>
            <pub-id pub-id-type="pmid">30140365</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kronstrand</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Guerrieri</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vikingsson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wohlfarth</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gr&#x000e9;en</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Fatal Poisonings Associated with New Psychoactive Substances.</article-title>
            <source>Handb Exp Pharmacol</source>
            <year>2018</year>
            <volume>252</volume>
            <fpage>495</fpage>
            <page-range>495-541</page-range>
            <pub-id pub-id-type="pmid">30105471</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simmler</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Liechti</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances.</article-title>
            <source>Handb Exp Pharmacol</source>
            <year>2018</year>
            <volume>252</volume>
            <fpage>143</fpage>
            <page-range>143-164</page-range>
            <pub-id pub-id-type="pmid">29633178</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Courtney</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Ray</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature.</article-title>
            <source>Drug Alcohol Depend</source>
            <year>2014</year>
            <month>Oct</month>
            <day>01</day>
            <volume>143</volume>
            <fpage>11</fpage>
            <page-range>11-21</page-range>
            <pub-id pub-id-type="pmid">25176528</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mellos</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Paparrigopoulos</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Substance use during the COVID-19 pandemic: What is really happening?</article-title>
            <source>Psychiatriki</source>
            <year>2022</year>
            <month>Mar</month>
            <day>28</day>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-20</page-range>
            <pub-id pub-id-type="pmid">35255473</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cisneros</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Ghorpade</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Methamphetamine and HIV-1-induced neurotoxicity: role of trace amine associated receptor 1 cAMP signaling in astrocytes.</article-title>
            <source>Neuropharmacology</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>85</volume>
            <fpage>499</fpage>
            <page-range>499-507</page-range>
            <pub-id pub-id-type="pmid">24950453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kevil</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Goeders</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Woolard</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Bhuiyan</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Dominic</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kolluru</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Arnold</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Traylor</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Orr</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Methamphetamine Use and Cardiovascular Disease.</article-title>
            <source>Arterioscler Thromb Vasc Biol</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>39</volume>
            <issue>9</issue>
            <fpage>1739</fpage>
            <page-range>1739-1746</page-range>
            <pub-id pub-id-type="pmid">31433698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tobolski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sawyer</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Afari</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Cardiovascular disease associated with methamphetamine use: a review.</article-title>
            <source>Heart Fail Rev</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>2059</fpage>
            <page-range>2059-2065</page-range>
            <pub-id pub-id-type="pmid">35844009</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Indave</surname>
                <given-names>BI</given-names>
              </name>
              <name>
                <surname>Sordo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bravo</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Sarasa-Renedo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-Balbuena</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>De la Fuente</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sonego</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Barrio</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Risk of stroke in prescription and other amphetamine-type stimulants use: A systematic review.</article-title>
            <source>Drug Alcohol Rev</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>56</fpage>
            <page-range>56-69</page-range>
            <pub-id pub-id-type="pmid">28485090</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Citron</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Halpern</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McCarron</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lundberg</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>McCormick</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pincus</surname>
                <given-names>IJ</given-names>
              </name>
              <name>
                <surname>Tatter</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Haverback</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Necrotizing angiitis associated with drug abuse.</article-title>
            <source>N Engl J Med</source>
            <year>1970</year>
            <month>Nov</month>
            <day>05</day>
            <volume>283</volume>
            <issue>19</issue>
            <fpage>1003</fpage>
            <page-range>1003-11</page-range>
            <pub-id pub-id-type="pmid">4394271</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Syed</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>TL</given-names>
              </name>
            </person-group>
            <article-title>Methylphenidate and dextroamphetamine-induced peripheral vasculopathy.</article-title>
            <source>J Clin Rheumatol</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>30</fpage>
            <page-range>30-3</page-range>
            <pub-id pub-id-type="pmid">18431096</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loewenhardt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bernhard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pierskalla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Neumann-Haefelin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hofmann</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Neurointerventional treatment of amphetamine-induced acute occlusion of the middle cerebral artery by intracranial balloon angioplasty.</article-title>
            <source>Clin Neuroradiol</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>137</fpage>
            <page-range>137-43</page-range>
            <pub-id pub-id-type="pmid">22173373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leith&#x000e4;user</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Langheinrich</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Rau</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Tillmanns</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Matthias</surname>
                <given-names>FR</given-names>
              </name>
            </person-group>
            <article-title>A 22-year-old woman with lower limb arteriopathy. Buerger's disease, or methamphetamine- or cannabis-induced arteritis?</article-title>
            <source>Heart Vessels</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-43</page-range>
            <pub-id pub-id-type="pmid">15700202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bostwick</surname>
                <given-names>DG</given-names>
              </name>
            </person-group>
            <article-title>Amphetamine induced cerebral vasculitis.</article-title>
            <source>Hum Pathol</source>
            <year>1981</year>
            <month>Nov</month>
            <volume>12</volume>
            <issue>11</issue>
            <fpage>1031</fpage>
            <page-range>1031-3</page-range>
            <pub-id pub-id-type="pmid">7319490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Angrist</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Corwin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bartlik</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Early pharmacokinetics and clinical effects of oral D-amphetamine in normal subjects.</article-title>
            <source>Biol Psychiatry</source>
            <year>1987</year>
            <month>Nov</month>
            <volume>22</volume>
            <issue>11</issue>
            <fpage>1357</fpage>
            <page-range>1357-68</page-range>
            <pub-id pub-id-type="pmid">3663788</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heal</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Gosden</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nutt</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Amphetamine, past and present--a pharmacological and clinical perspective.</article-title>
            <source>J Psychopharmacol</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>479</fpage>
            <page-range>479-96</page-range>
            <pub-id pub-id-type="pmid">23539642</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santagati</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Ferrara</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Marrazzo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ronsisvalle</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Simultaneous determination of amphetamine and one of its metabolites by HPLC with electrochemical detection.</article-title>
            <source>J Pharm Biomed Anal</source>
            <year>2002</year>
            <month>Sep</month>
            <day>05</day>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>247</fpage>
            <page-range>247-55</page-range>
            <pub-id pub-id-type="pmid">12191709</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brams</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mao</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Doyle</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder.</article-title>
            <source>Postgrad Med</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>120</volume>
            <issue>3</issue>
            <fpage>69</fpage>
            <page-range>69-88</page-range>
            <pub-id pub-id-type="pmid">18824827</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cody</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Schwarzhoff</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Fluorescence polarization immunoassay detection of amphetamine, methamphetamine, and illicit amphetamine analogues.</article-title>
            <source>J Anal Toxicol</source>
            <year>1993</year>
            <season>Jan-Feb</season>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-33</page-range>
            <pub-id pub-id-type="pmid">8429622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spiller</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Weston</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Jansen</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>49</volume>
            <issue>6</issue>
            <fpage>499</fpage>
            <page-range>499-505</page-range>
            <pub-id pub-id-type="pmid">21824061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DePriest</surname>
                <given-names>AZ</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Doering</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Black</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Pseudoephedrine and false-positive immunoassay urine drug tests for amphetamine.</article-title>
            <source>Pharmacotherapy</source>
            <year>2013</year>
            <month>May</month>
            <volume>33</volume>
            <issue>5</issue>
            <fpage>e88</fpage>
            <page-range>e88-9</page-range>
            <pub-id pub-id-type="pmid">23065913</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bedussi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Acerbis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Noseda</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Demagistri</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zamprogno</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ceschi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>False-positive urine screen test for MDMA in a patient exposed to mebeverine.</article-title>
            <source>Br J Clin Pharmacol</source>
            <year>2021</year>
            <month>May</month>
            <volume>87</volume>
            <issue>5</issue>
            <fpage>2397</fpage>
            <page-range>2397-2398</page-range>
            <pub-id pub-id-type="pmid">33200465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leclercq</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Soichot</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Delhotal-Landes</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bourgogne</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gourlain</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>M&#x000e9;garbane</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Labat</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>False positive amphetamines and 3,4-methylenedioxymethamphetamine immunoassays in the presence of metoprolol-two cases reported in clinical toxicology.</article-title>
            <source>J Anal Toxicol</source>
            <year>2020</year>
            <month>Mar</month>
            <day>07</day>
            <volume>44</volume>
            <issue>2</issue>
            <fpage>200</fpage>
            <page-range>200-205</page-range>
            <pub-id pub-id-type="pmid">31384953</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wijngaard</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Parra-Robert</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mar&#x000e9;s</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Escalante</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Salgado</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-de-la-Presa</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>To-Figueras</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Brunet</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Tetracaine from urethral ointment causes false positive amphetamine results by immunoassay.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>59</volume>
            <issue>6</issue>
            <fpage>500</fpage>
            <page-range>500-505</page-range>
            <pub-id pub-id-type="pmid">33112680</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vorce</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Holler</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Cawrse</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Magluilo</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Dimethylamylamine: a drug causing positive immunoassay results for amphetamines.</article-title>
            <source>J Anal Toxicol</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>183</fpage>
            <page-range>183-7</page-range>
            <pub-id pub-id-type="pmid">21439156</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaplan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Faley</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Case Reports of Aripiprazole Causing False-Positive Urine Amphetamine Drug Screens in Children.</article-title>
            <source>Pediatrics</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>136</volume>
            <issue>6</issue>
            <fpage>e1625</fpage>
            <page-range>e1625-8</page-range>
            <pub-id pub-id-type="pmid">26527556</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wheeler</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Rymer</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Lower</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zona</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Peck Palmer</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Tamama</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Ranitidine interference with standard amphetamine immunoassay.</article-title>
            <source>Clin Chim Acta</source>
            <year>2015</year>
            <month>Jan</month>
            <day>01</day>
            <volume>438</volume>
            <fpage>307</fpage>
            <page-range>307-8</page-range>
            <pub-id pub-id-type="pmid">25242739</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pisani</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Oteri</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Di Raimondo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Di Perri</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Effects of psychotropic drugs on seizure threshold.</article-title>
            <source>Drug Saf</source>
            <year>2002</year>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>91</fpage>
            <page-range>91-110</page-range>
            <pub-id pub-id-type="pmid">11888352</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kreuzer</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Landgrebe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wittmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schecklmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Poeppl</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Hajak</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Langguth</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Hypothermia associated with antipsychotic drug use: a clinical case series and review of current literature.</article-title>
            <source>J Clin Pharmacol</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>52</volume>
            <issue>7</issue>
            <fpage>1090</fpage>
            <page-range>1090-7</page-range>
            <pub-id pub-id-type="pmid">21956608</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shiloh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Schapir</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bar-Ziv</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Stryjer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Konas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Louis</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hermesh</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Munitz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Weizman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Valevski</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Association between corneal temperature and mental status of treatment-resistant schizophrenia inpatients.</article-title>
            <source>Eur Neuropsychopharmacol</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>19</volume>
            <issue>9</issue>
            <fpage>654</fpage>
            <page-range>654-8</page-range>
            <pub-id pub-id-type="pmid">19493658</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Evers</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Calcagnoli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>van Dijk</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Scheurink</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Olanzapine causes hypothermia, inactivity, a deranged feeding pattern and weight gain in female Wistar rats.</article-title>
            <source>Pharmacol Biochem Behav</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>97</volume>
            <issue>1</issue>
            <fpage>163</fpage>
            <page-range>163-9</page-range>
            <pub-id pub-id-type="pmid">20570692</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ray</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Bujarski</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Courtney</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Moallem</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Lunny</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Roche</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Leventhal</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Shoptaw</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Heinzerling</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>London</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Miotto</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.</article-title>
            <source>Neuropsychopharmacology</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>40</volume>
            <issue>10</issue>
            <fpage>2347</fpage>
            <page-range>2347-56</page-range>
            <pub-id pub-id-type="pmid">25801501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moerke</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Banks</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Negus</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Maintenance on naltrexone+amphetamine decreases cocaine-vs.-food choice in male rhesus monkeys.</article-title>
            <source>Drug Alcohol Depend</source>
            <year>2017</year>
            <month>Dec</month>
            <day>01</day>
            <volume>181</volume>
            <fpage>85</fpage>
            <page-range>85-93</page-range>
            <pub-id pub-id-type="pmid">29040826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sakloth</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Negus</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Naltrexone maintenance fails to alter amphetamine effects on intracranial self-stimulation in rats.</article-title>
            <source>Exp Clin Psychopharmacol</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>195</fpage>
            <page-range>195-204</page-range>
            <pub-id pub-id-type="pmid">29528663</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guterstam</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jayaram-Lindstr&#x000f6;m</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Berrebi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Petrovic</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ingvar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fransson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Franck</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Cue reactivity and opioid blockade in amphetamine dependence: A randomized, controlled fMRI study.</article-title>
            <source>Drug Alcohol Depend</source>
            <year>2018</year>
            <month>Oct</month>
            <day>01</day>
            <volume>191</volume>
            <fpage>91</fpage>
            <page-range>91-97</page-range>
            <pub-id pub-id-type="pmid">30096639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stoops</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Pike</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hays</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Glaser</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Rush</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine.</article-title>
            <source>Pharmacol Biochem Behav</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>129</volume>
            <fpage>45</fpage>
            <page-range>45-50</page-range>
            <pub-id pub-id-type="pmid">25459104</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Winsl&#x000f8;w</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Vertebral Artery Dissection Related to Amphetamine Abuse - A Case Report.</article-title>
            <source>J Cent Nerv Syst Dis</source>
            <year>2020</year>
            <volume>12</volume>
            <fpage>1179573520939340</fpage>
            <pub-id pub-id-type="pmid">32655281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Suojanen</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Colucci</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Rumbaugh</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Hollenberg</surname>
                <given-names>NK</given-names>
              </name>
            </person-group>
            <article-title>Cocaine- and methamphetamine-induced acute cerebral vasospasm: an angiographic study in rabbits.</article-title>
            <source>AJNR Am J Neuroradiol</source>
            <year>1990</year>
            <season>Nov-Dec</season>
            <volume>11</volume>
            <issue>6</issue>
            <fpage>1141</fpage>
            <page-range>1141-6</page-range>
            <pub-id pub-id-type="pmid">2124040</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buxton</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>McConachie</surname>
                <given-names>NS</given-names>
              </name>
            </person-group>
            <article-title>Amphetamine abuse and intracranial haemorrhage.</article-title>
            <source>J R Soc Med</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>93</volume>
            <issue>9</issue>
            <fpage>472</fpage>
            <page-range>472-7</page-range>
            <pub-id pub-id-type="pmid">11089483</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goyal</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sethi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of recreational substance use in patients presenting with seizures to a tertiary care hospital.</article-title>
            <source>Epilepsy Behav</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>125</volume>
            <fpage>108419</fpage>
            <pub-id pub-id-type="pmid">34837845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Madea</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ruppel</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Prangenberg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kr&#x000e4;mer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Doberentz</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Expression of heat shock proteins 27, 60, and 70 in amphetamine and cocaine associated deaths.</article-title>
            <source>Forensic Sci Int</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>329</volume>
            <fpage>111088</fpage>
            <pub-id pub-id-type="pmid">34773820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Green</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Cross</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Goodwin</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").</article-title>
            <source>Psychopharmacology (Berl)</source>
            <year>1995</year>
            <month>Jun</month>
            <volume>119</volume>
            <issue>3</issue>
            <fpage>247</fpage>
            <page-range>247-60</page-range>
            <pub-id pub-id-type="pmid">7675958</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Connor</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Rusyniak</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Bruno</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Cerebrovascular and cardiovascular complications of alcohol and sympathomimetic drug abuse.</article-title>
            <source>Med Clin North Am</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>89</volume>
            <issue>6</issue>
            <fpage>1343</fpage>
            <page-range>1343-58</page-range>
            <pub-id pub-id-type="pmid">16227066</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pozoga</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Snopek</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dabrowski</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Acute coronary syndrome after amphetamine use in a young male with myocardial bridging--a case report].</article-title>
            <source>Kardiol Pol</source>
            <year>2005</year>
            <month>Apr</month>
            <volume>62</volume>
            <issue>4</issue>
            <fpage>381</fpage>
            <page-range>381-2</page-range>
            <pub-id pub-id-type="pmid">15928743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kueh</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Gabriel</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Lund</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sutton</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bradley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kerr</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Looi</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Clinical Characteristics and Outcomes of Patients with Amphetamine-Associated Cardiomyopathy in South Auckland, New Zealand.</article-title>
            <source>Heart Lung Circ</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>25</volume>
            <issue>11</issue>
            <fpage>1087</fpage>
            <page-range>1087-1093</page-range>
            <pub-id pub-id-type="pmid">27185546</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jacobs</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Fatal amphetamine-associated cardiotoxicity and its medicolegal implications.</article-title>
            <source>Am J Forensic Med Pathol</source>
            <year>2006</year>
            <month>Jun</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>156</fpage>
            <page-range>156-60</page-range>
            <pub-id pub-id-type="pmid">16738435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ayme-Dietrich</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lawson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>C&#x000f4;t&#x000e9;</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>de Tapia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Da Silva</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ebel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hechler</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gachet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Guyonnet</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rouillard</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Stoltz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Quentin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Banas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Daubeuf</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Frossard</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gasser</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mazzucotelli</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Hermine</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Maroteaux</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Monassier</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>The role of 5-HT<sub>2B</sub> receptors in mitral valvulopathy: bone marrow mobilization of endothelial progenitors.</article-title>
            <source>Br J Pharmacol</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>174</volume>
            <issue>22</issue>
            <fpage>4123</fpage>
            <page-range>4123-4139</page-range>
            <pub-id pub-id-type="pmid">28806488</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Naqvi</surname>
                <given-names>TZ</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>Anorexigen-induced cardiac valvulopathy and female gender.</article-title>
            <source>Curr Womens Health Rep</source>
            <year>2003</year>
            <month>Apr</month>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>116</fpage>
            <page-range>116-25</page-range>
            <pub-id pub-id-type="pmid">12628081</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Westover</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Nakonezny</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Aortic dissection in young adults who abuse amphetamines.</article-title>
            <source>Am Heart J</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>160</volume>
            <issue>2</issue>
            <fpage>315</fpage>
            <page-range>315-21</page-range>
            <pub-id pub-id-type="pmid">20691838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Swalwell</surname>
                <given-names>CI</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>GG</given-names>
              </name>
            </person-group>
            <article-title>Methamphetamine as a risk factor for acute aortic dissection.</article-title>
            <source>J Forensic Sci</source>
            <year>1999</year>
            <month>Jan</month>
            <volume>44</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-6</page-range>
            <pub-id pub-id-type="pmid">9987866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hu</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis observed at forensic autopsy: a series of 52 cases.</article-title>
            <source>Forensic Sci Med Pathol</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>424</fpage>
            <page-range>424-431</page-range>
            <pub-id pub-id-type="pmid">30056625</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farah</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Farah</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Ecstasy (3,4-methylenedioxymethamphetamine)-induced inappropriate antidiuretic hormone secretion.</article-title>
            <source>Pediatr Emerg Care</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>24</volume>
            <issue>9</issue>
            <fpage>615</fpage>
            <page-range>615-7</page-range>
            <pub-id pub-id-type="pmid">18797371</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Panikkath</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Panikkath</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Amphetamine-related ischemic colitis causing gastrointestinal bleeding.</article-title>
            <source>Proc (Bayl Univ Med Cent)</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>325</fpage>
            <page-range>325-6</page-range>
            <pub-id pub-id-type="pmid">27365888</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Green</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Battersby</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Heath</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>McCrossan</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>A fatal case of amphetamine induced ischaemic colitis.</article-title>
            <source>Ann R Coll Surg Engl</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>99</volume>
            <issue>7</issue>
            <fpage>e200</fpage>
            <page-range>e200-e201</page-range>
            <pub-id pub-id-type="pmid">28853604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kurtz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Alshoubi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gehres</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Methamphetamine-Induced Bowel Ischemia in a 50-Year-Old Male.</article-title>
            <source>Case Rep Crit Care</source>
            <year>2022</year>
            <volume>2022</volume>
            <fpage>9690034</fpage>
            <pub-id pub-id-type="pmid">35402052</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Attaran</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Fatal Small Intestinal Ischemia Due to Methamphetamine Intoxication: Report of a Case With Autopsy Results.</article-title>
            <source>Acta Med Iran</source>
            <year>2017</year>
            <month>May</month>
            <volume>55</volume>
            <issue>5</issue>
            <fpage>344</fpage>
            <page-range>344-347</page-range>
            <pub-id pub-id-type="pmid">28724276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Medhus</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rognli</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Gossop</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Holm</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>M&#x000f8;rland</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bramness</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Amphetamine-induced psychosis: Transition to schizophrenia and mortality in a small prospective sample.</article-title>
            <source>Am J Addict</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>24</volume>
            <issue>7</issue>
            <fpage>586</fpage>
            <page-range>586-9</page-range>
            <pub-id pub-id-type="pmid">26332037</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ginovart</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Farde</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Halldin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Swahn</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates.</article-title>
            <source>Synapse</source>
            <year>1999</year>
            <month>Feb</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>154</fpage>
            <page-range>154-62</page-range>
            <pub-id pub-id-type="pmid">10024013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boileau</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Dagher</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Leyton</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gunn</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Diksic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Benkelfat</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men.</article-title>
            <source>Arch Gen Psychiatry</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>63</volume>
            <issue>12</issue>
            <fpage>1386</fpage>
            <page-range>1386-95</page-range>
            <pub-id pub-id-type="pmid">17146013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>PI</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Miyagawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tojais</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Hennigs</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Sweeney</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Inglis</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Rabinovitch</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Amphetamines promote mitochondrial dysfunction and DNA damage in pulmonary hypertension.</article-title>
            <source>JCI Insight</source>
            <year>2017</year>
            <month>Jan</month>
            <day>26</day>
            <volume>2</volume>
            <issue>2</issue>
            <fpage>e90427</fpage>
            <pub-id pub-id-type="pmid">28138562</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Wolferen</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Vonk Noordegraaf</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boonstra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Postmus</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>[Pulmonary arterial hypertension due to the use of amphetamines as drugs or doping].</article-title>
            <source>Ned Tijdschr Geneeskd</source>
            <year>2005</year>
            <month>Jun</month>
            <day>04</day>
            <volume>149</volume>
            <issue>23</issue>
            <fpage>1283</fpage>
            <page-range>1283-8</page-range>
            <pub-id pub-id-type="pmid">15960135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zamanian</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Hedlin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Greuenwald</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Segal</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Jorden</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kudelko</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hsi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rupp</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sweatt</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Tuder</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Berry</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Rabinovitch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Doyle</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>de Jesus Perez</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kawut</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2018</year>
            <month>Mar</month>
            <day>15</day>
            <volume>197</volume>
            <issue>6</issue>
            <fpage>788</fpage>
            <page-range>788-800</page-range>
            <pub-id pub-id-type="pmid">28934596</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seiden</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Sabol</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Ricaurte</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Amphetamine: effects on catecholamine systems and behavior.</article-title>
            <source>Annu Rev Pharmacol Toxicol</source>
            <year>1993</year>
            <volume>33</volume>
            <fpage>639</fpage>
            <page-range>639-77</page-range>
            <pub-id pub-id-type="pmid">8494354</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ross</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Banks</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rezannah</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Daglish</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of malnutrition and nutritional risk factors in patients undergoing alcohol and drug treatment.</article-title>
            <source>Nutrition</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>28</volume>
            <issue>7-8</issue>
            <fpage>738</fpage>
            <page-range>738-43</page-range>
            <pub-id pub-id-type="pmid">22356728</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laslett</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Dietze</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dwyer</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The oral health of street-recruited injecting drug users: prevalence and correlates of problems.</article-title>
            <source>Addiction</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>103</volume>
            <issue>11</issue>
            <fpage>1821</fpage>
            <page-range>1821-5</page-range>
            <pub-id pub-id-type="pmid">19032532</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smart</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Rosenberg</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Methamphetamine abuse: medical and dental considerations.</article-title>
            <source>J Mass Dent Soc</source>
            <year>2005</year>
            <season>Summer</season>
            <volume>54</volume>
            <issue>2</issue>
            <fpage>44</fpage>
            <page-range>44-6, 48-9</page-range>
            <pub-id pub-id-type="pmid">16149403</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yeh</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Chiang</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Mao</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Kao</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Tzeng</surname>
                <given-names>NS</given-names>
              </name>
            </person-group>
            <article-title>Aripiprazole treatment in a case of amphetamine-induced delusional infestation.</article-title>
            <source>Aust N Z J Psychiatry</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>48</volume>
            <issue>7</issue>
            <fpage>681</fpage>
            <page-range>681-2</page-range>
            <pub-id pub-id-type="pmid">24563196</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rhee</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Albertson</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Douglas</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Choreoathetoid disorder associated with amphetamine-like drugs.</article-title>
            <source>Am J Emerg Med</source>
            <year>1988</year>
            <month>Mar</month>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>131</fpage>
            <page-range>131-3</page-range>
            <pub-id pub-id-type="pmid">3355623</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30305.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lundh</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tunving</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>An extrapyramidal choreiform syndrome caused by amphetamine addiction.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>1981</year>
            <month>Aug</month>
            <volume>44</volume>
            <issue>8</issue>
            <fpage>728</fpage>
            <page-range>728-30</page-range>
            <pub-id pub-id-type="pmid">7299411</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
